Completion of whole genome sequence of a Parsi breast cancer patient
First Whole Genome Sequencing of Parsi Breast Cancer Patient Completed
All genetic variants linked to the disease can be identified by employing whole-genome sequencing of affected individuals
Avesthagen, a leading knowledge based life sciences company pioneering the convergence between food, pharma and population genetics, has recently announced the completion of whole genome sequence of a Parsi breast cancer patient. Employing whole-genome sequencing of affected individuals all genetic variants linked to the disease can be identified.